Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2011, Vol. 31 Issue (04): 12-17    DOI:
    
Effect of RMP Gene on Genome Stability and Apoptosis of Hepatoma Carcinoma Cells
WANG Xiao-tin, LI Min, LIAN Xiao-nin, YANG Hui-cui, CAO Kai, GUO Yun-lan, ZHONG Lei, WEI Weng-xiang
Department of Cellular and Molecular Biology,Medical Suzhou University,Suzhou 215123,China
Download: HTML   PDF(1103KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To explore the effect of RPB5-Mediating Protein on cell genome stability and apoptosis of human hepatocellular carcinoma cell. Methods:RT-PCR was used to detect the expression of RMP mRNA on normal cell lines and several tumour cell lines. The SMMC-7721 cells and human hepatic cell HL-7702 cells were exposed to60Co γ-ray of different dose; then semiquantitative RT-PCR assay was used to detect the expression of RMP; Flow cytometric technique were used to detect apoptosis and cell cycle. To study the effect of RMP on cell genome stability and apoptosis of human hepatocellular carcinoma cell by RNA interfere . Results:RMP could express in different normal cell lines and tumour cell lines. The expression of RMP gene increased with the increase of exposure dosage. Flow cytometry results also indicated that cell apoptosis increased with increasing dosage, with the number of cells in G1 stage increased and that in S stage decreased. After RMP gene was interfered, the morphocytology of the cells changed obviously, meanwhile, the expression of p21 decreased. Conclusions:RMP may have a potential role on maintaining cell genome stability. RMP may associate with p53、p21, which have an role on regulating apoptosis.



Key wordsHepatoma carcinoma cell      RNA interference      RMP gene      Radiotherapy      Genome stability     
Received: 23 July 2010      Published: 26 April 2011
ZTFLH:  Q819  
Cite this article:

WANG Xiao-tin, LI Min, LIAN Xiao-nin, YANG Hui-cui, CAO Kai, GUO Yun-lan, ZHONG Lei, WEI Weng-xiang. Effect of RMP Gene on Genome Stability and Apoptosis of Hepatoma Carcinoma Cells. China Biotechnology, 2011, 31(04): 12-17.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2011/V31/I04/12


[1] Cheong J H, Yi M, Lin Y,et al. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitisB virus X protein and may play a role in X transactivation.EMBO J,1995,14(1):143-150.

[2] Dorjsuren D, Lin Y, Wei W,et al. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein.Mol Cell Biol, 1998,18(12):7546-7555.

[3] Delgermaal, Hayashi N, Dorjsuren D, et al. Subcellular localization of RPB5-mediating protein and its putative functional partner.Mol Cell Biol,2004, 24(19):8556-8566.

[4] Wei W, Gu J X, Zhu C Q,et al.Interaction with general transcription factorIIF(TFIIF)is required for the suppression of activated transcription by RPB5-mediating protein(RMP) .Cell Res,2003,13(2):111-120.

[5] Tang H, Oishi N, Kaneko S,et al. Molecular function and biological roles of hepatitis B virus x protein.Cancer Sci, 2006 ,97(10):977-983.

[6] Keasler V V, Hodgson A J, Madden C R, et al. Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol,2007,81(6):2656-2662.

[7] Lee A T, Ren J,Wong E T, et al .The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage.J Biol Chem,2005,280(39):33525-33535.

[8] Morrison A J,Shen X. DNA repair in the context of chromatin. Cell Cycle,2005, 4(4):568-571.

[9] Christine T P, Ekaterini A K, Michael O H,et al. URI-1 is required for DNA stability in C. elegans.Development ,2006,133(4):621-629.

[10] Quevedo C, Kaplan D R, Derry W B. AKT-1 regulates DNA-damage-induced germline apoptosis in C. elegans. Curr Biol, 2007,17(3):286-292.

[11] Salinas L S, Maldonado E, Navarro R E. Stress-induced germ cell apoptosis by a p53 independent pathway in Caenorhabditis elegans. Cell Death Differ, 2006,13(12):2129-2139.

[12] Arenz C, Schepers U. RNA interference: from an ancient mechanism to a state of the art therapeutic application. Naturwissenschaften, 2003, 90(8):345-359.

[13] Ryther R C, Flynt A S, Phillips J A, et al. siRNA therapeutics: big potential from small RNAs. Gene Ther,2005, 12(1):5-11.

[14] Joshua-Tor L. siRNAs at RISC. Structure, 2004, 12(7):1120-1122.

[15] Reynolds A, Leake D, Boese Q, et al. Rational siRNA design for RNA interference. Nat Biotechnol, 2004,22(3):326-330.

[16] Gartel A L,Radhakrishnan S K.Lost in transeription:p2l repressionmechanisms,and consequences.Cancer Res,2005,65(10):3980-3985.

[1] FENG Zhao,LI Jiang-hao,WANG Jia-hua. Functional Analysis of RpRPL22, a Ribosomal Protein Homologous Gene, in the Symbiotic Nodulation Process of Robinia Pseudoacacia[J]. China Biotechnology, 2021, 41(7): 10-21.
[2] Yu CHENG,Qiong SHI,Li-qin AN,Meng-tian FAN,Gai-gai HUANG,Ya-guang WENG. BMP7 Gene Silencing Inhibits Osteogenic Differentiation of Porcine Arotic Valve Interstitial Cells Induced by Osteogenic Induction Medium[J]. China Biotechnology, 2019, 39(5): 63-71.
[3] Zhao FENG,Min-xia CHOU. Functional Analysis of Rpfan37 in the Symbiotic Nodulation Process of Robinia Pseudoacacia[J]. China Biotechnology, 2018, 38(5): 47-55.
[4] DONG Wei-peng,ZHANG Shao-hua,XU Xiang,YAN Jiong. The Effect and Mechanism of Down-Regulated Fsp27 Gene Combined with Myricetin on Lipolysis of 3T3-L1 Adipocytes[J]. China Biotechnology, 2018, 38(12): 7-13.
[5] LIU Yi-xuan, BIAN Zhen, MA Hong-mei. Progress and Prospect of Cancer Gene Therapy[J]. China Biotechnology, 2016, 36(5): 106-111.
[6] HU Na, LIU Qing, TANG Zhao-yong, TANG He-jing, AO Lan, ZHAO Zi-hao, FANG Liao-qiong. siRNA Inhibits the Growth and Migration of Mouse Melanoma by MMP-9 and FAK Gene[J]. China Biotechnology, 2016, 36(5): 34-39.
[7] ZHAO Zhi-wu, WANG Jun-shi, MA Min, ZHANG Shao-hua, YAN Jiong. Effect of Down-regulated Perilipin 1 Gene Expression on Lipolysis of 3T3-L1 Adipocytes[J]. China Biotechnology, 2016, 36(3): 17-22.
[8] XUE Yu-wen, LI Tie-jun, ZHOU Jia-ming, CHEN Li. The Application and Perspectives of Multi-target RNAi in the Research and Development of Gene Therapy[J]. China Biotechnology, 2015, 35(1): 75-81.
[9] SU Lan, ZHANG Ping, WANGYANG Jun-qi, ZHONG Ru-gang. Progress on the Inhibition of Hepatitis B virus by siRNA Strategy[J]. China Biotechnology, 2014, 34(9): 102-107.
[10] TANG He-jing, TANG Zhao-yong, LIU Long-xing, ZHANG Xiao-mei, WANG Yi-ting, FANG Liao-qiong. Effect of siRNA Combined-silencing MMP-9 and FAK on Invasion and Migration of Mouse Melanoma Highly Metastatic Cells B16F10 in vitro[J]. China Biotechnology, 2014, 34(9): 40-47.
[11] HUANG Tian-qing, KONG Qing-ran, LI Yan, YU Miao, LIU Zhong-hua. The Effect of Insulin Receptor Substrates 1 and 2 Knockdown on Porcine Hepatic Glucolipid Metabolism[J]. China Biotechnology, 2014, 34(4): 27-35.
[12] PANG Min, WANG Hai-long, GUO Min, GUO Rui. Construction of an Eukaryocyte Expression Vector of Human ANKRD49 and the Study of Function and RNA Interference Target of ANKRD49[J]. China Biotechnology, 2014, 34(10): 15-21.
[13] ZHANG Hao-ran, ZENG Zhi-yong, CHEN Jun-min. The Influence of Downregulation of DEPTOR Expression by RNA Interference on the Proliferation and Apoptosis of Human Multiple Myeloma Cells in vitro[J]. China Biotechnology, 2013, 33(5): 13-21.
[14] SUN Ying, GE Feng, LIU Di-qiu, RAO Jian. Effects of CAS Silencing by RNAi on the Content of Saponins in Panax notoginseng[J]. China Biotechnology, 2013, 33(3): 80-85.
[15] GUO Yun-lan, YANG Hui-cui, LIAN Xiao-ning, CAO Kai, WANG Xiao-ting, ZHONG Lei, WEI Wen-xiang. Effects of RPB5-mediating Protein (RMP) on Cell Cycle of Hepatoma Cells[J]. China Biotechnology, 2011, 31(5): 8-14.